Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Mellisa Renteria, Misbah Jilani, Michael J Brockman & Harry E Davis. (2023) Inflammatory Myositis Following Statin Use in a Patient With Untreated Hypothyroidism. Cureus.
Crossref
Crossref
Fernando Poli De Frias, Ryan Keith Petit, Carlos Peña, Francesca Polit, Robert Poppiti & Carlos Sesin. (2023) Concomitant Use of Steroids and Immunotherapy in a Patient With Paraneoplastic Dermatomyositis and Gastroesophageal Adenocarcinoma. Cureus.
Crossref
Crossref
Yumiko Mizuhashi, Shinya Hirata, Komei Sakata, Eiko Miyagawa, Mikako Iwakura, Masayuki Murai, Tsuneo Sasai & Masao Matsuoka. (2023) Overlap syndrome involving anti-OJ antibody-positive polymyositis, systemic lupus erythematosus and Sjögren’s syndrome: A case report and literature review. Modern Rheumatology Case Reports 7:2, pages 399-403.
Crossref
Crossref
Pei Zhou, Qinxue Shen, Shiting Zhou, Xiaoli Ouyang, Ting Guo, Min Song, Wei Guo, Yi Zhang & Hong Peng. (2023) The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study. Scientific Reports 13:1.
Crossref
Crossref
Tomoyuki Mutoh, Mikihiro Takahashi, Taichi Nagai & Masataka Kudo. (2023) Does the BNT162b2 Vaccine Trigger Antimelanoma Differentiation-Associated Gene 5 Antibody–Positive Interstitial Lung Disease?. The Journal of Rheumatology 50:2, pages 293-294.
Crossref
Crossref
Fatema M Dubai & Ahmed Isa. (2023) Overlap Syndrome in a Male Presenting With Progressive Lower Limb Weakness: A Case Report. Cureus.
Crossref
Crossref
Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Raisa Kraaijvanger, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel & Jan C. Grutters. (2022) Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases. PLOS ONE 17:11, pages e0277007.
Crossref
Crossref
Roi F Medina & John Jahan. (2022) Management of Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Positive Dermatomyositis in an Acute Rehabilitation Center: A Case Report. Cureus.
Crossref
Crossref
Morgana K. Kellogg, Elena B. Tikhonova & Andrey L. Karamyshev. (2022) Signal Recognition Particle in Human Diseases. Frontiers in Genetics 13.
Crossref
Crossref
Sung Soo Ahn, Yong-Beom Park & Sang-Won Lee. (2022) Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis. Journal of Clinical Medicine 11:7, pages 2052.
Crossref
Crossref
Satoshi Hama, Misako Higashida-Konishi, Mitsuhiro Akiyama, Tatsuya Shimada, Hiroshi Takei, Keisuke Izumi, Hisaji Oshima & Yutaka Okano. (2022) Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy. Internal Medicine 61:7, pages 1085-1091.
Crossref
Crossref
Manpreet Basuita & Lee M Fidler. (2022) Myositis Antibodies and Interstitial Lung Disease. The Journal of Applied Laboratory Medicine 7:1, pages 240-258.
Crossref
Crossref
Avanish Jha, John Mathew, JohnAntony Jude Prakash & SusmithaKarunasree Perumalla. (2022) Clinical profile of anti-transcription intermediary factor-1 gamma-positive adults from a single tertiary care center. Current Medical Issues 20:2, pages 99.
Crossref
Crossref
Dominika Kwiatkowska & Adam Reich. (2021) The Significance of Autoantibodies in Juvenile Dermatomyositis. BioMed Research International 2021, pages 1-6.
Crossref
Crossref
Julia Lauinger, Kamran Ghoreschi & Sebastian Volc. (2021) Charakteristika von Dermatomyositis‐Patienten mit und ohne Malignom‐Assoziation. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:11, pages 1601-1612.
Crossref
Crossref
Julia Lauinger, Kamran Ghoreschi & Sebastian Volc. (2021) Characteristics of dermatomyositis patients with and without associated malignancy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 19:11, pages 1601-1611.
Crossref
Crossref
Yuichi Yamasaki, Norimoto Kobayashi, Shinji Akioka, Kazuko Yamazaki, Shunichiro Takezaki, Haruna Nakaseko, Asami Ohara, Kenichi Nishimura, Yutaka Nishida, Satoshi Sato, Takayuki Kishi, Motomu Hashimoto, Masaaki Mori, Yuka Okazaki, Masataka Kuwana & Akiko Ohta. (2021) Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study. Rheumatology 60:10, pages 4821-4831.
Crossref
Crossref
Andrea Tešija Kuna, Lovorka Đerek, Vedrana Drvar, Ana Kozmar & Katarina Gugo. (2021) Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochemia medica 31:2, pages 210-229.
Crossref
Crossref
Neelam Hassan, Emma Jane Davies, Benjamin George Faber & Harsha Gunawardena. (2021) Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis. Rheumatology 60:5, pages e156-e158.
Crossref
Crossref
Ling Zhao, Kaisheng Su, Tao Liu, Dejun Sun & Zhenyu Jiang. (2020) Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity. Clinical Rheumatology 40:3, pages 1009-1016.
Crossref
Crossref
Jung-Lung Hsu, Ming-Feng Liao, Chun-Che Chu, Hung-Chou Kuo, Rong-Kuo Lyu, Hong-Shiu Chang, Chiung-Mei Chen, Yih-Ru Wu, Kuo-Hsuan Chang, Yi-Ching Weng, Chun-Wei Chang, Hsing-I. Chiang, Chih-Kuang Cheng, Pai-Wei Lee, Chin-Chang Huang & Long-Sun Ro. (2021) Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan. Scientific Reports 11:1.
Crossref
Crossref
Hiroki Fujii, Takashi Kurashige, Satoshi Kubo, Ran Nakashima, Yasuhito Hamaguchi & Takeshi Kitamura. (2021) Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with the preferential involvement of neck extensors: a case report頸部伸筋優位の筋障害を生じた抗nuclear matrix protein 2抗体陽性皮膚筋炎の1例. Rinsho Shinkeigaku 61:11, pages 743-749.
Crossref
Crossref
Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel & Jan C. Grutters. (2020) Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease. Journal of Clinical Medicine 9:9, pages 2944.
Crossref
Crossref
C. Jalles, A. Deroux, M. Tardieu, M. Lugosi, S. Viel, O. Benveniste & B. Colombe. (2020) Dermatomyosite à anticorps anti-MDA5 sévère associée à un cancer et contrôlée par inhibiteur de JAK. La Revue de Médecine Interne 41:6, pages 421-424.
Crossref
Crossref
Melody P. Chung, Carrie Richardson, David Kirakossian, Amir B. Orandi, Lesley A. Saketkoo, Lisa G. Rider, Adam Schiffenbauer, Carlos A. von Mühlen & Lorinda Chung. (2020) Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis. Autoimmunity Reviews 19:6, pages 102533.
Crossref
Crossref
Domenico Sambataro, Gianluca Sambataro, Francesca Pignataro, Giovanni Zanframundo, Veronica Codullo, Evelina Fagone, Emanuele Martorana, Francesco Ferro, Martina Orlandi, Nicoletta Del Papa, Lorenzo Cavagna, Lorenzo Malatino, Michele Colaci & Carlo Vancheri. (2020) Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?. Diagnostics 10:4, pages 208.
Crossref
Crossref
Aleksandra Opinc, Joanna Sarnik, Olga Brzezińska, Marcin Makowski, Anna Lewandowska-Polak & Joanna Makowska. (2020) Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study. Rheumatology International.
Crossref
Crossref